PA
VOR icon

Parallel Advisors’s Vor Biopharma VOR Stock Holding History

Parallel Advisors’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$856 Buy
+48
New +$677 ﹤0.01% 3566
2022
Q1 		– Sell
-25
Closed -$6K – 3292
2021
Q4 		$6K Buy
25
+21
+525% +$6.05K ﹤0.01% 2354
2021
Q3 		$1K Buy
4
+2
+100% +$595 ﹤0.01% 2975
2021
Q2 		$1K Buy
+2
New +$987 ﹤0.01% 2842

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parallel Advisors's VOR Position: Q1 2026 in Review

Parallel Advisors opened a new position in Vor Biopharma (VOR) in Q1 2026: 48 shares worth $856. The stake represents ﹤0.01% of the portfolio and ranks #3566 among its holdings. This is a return to the name: Parallel Advisors previously reported a position in VOR as recently as Q4 2021.

Parallel Advisors first reported a position in VOR in Q2 2021 and has held it in 4 quarters since. The position peaked at $6K in Q4 2021. 80 funds tracked by Wall St. Rank hold VOR as of Q1 2026.

  • Parallel Advisors held 48 shares of Vor Biopharma worth $856 as of Q1 2026.
  • Vor Biopharma was a new Parallel Advisors position in Q1 2026.
  • Vor Biopharma made up ﹤0.01% of Parallel Advisors's portfolio in Q1 2026, its #3566 holding.
  • Parallel Advisors first reported a position in Vor Biopharma in Q2 2021 and has held it in 4 quarters since.
  • Parallel Advisors's Vor Biopharma position peaked at $6K in Q4 2021.
  • 80 funds tracked by Wall St. Rank held Vor Biopharma as of Q1 2026.

Based on Parallel Advisors's 13F filing for Q1 2026, filed 7 May 2026.